J06BB05 • specific rabies immunoglobulin • Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins
Specific anti-rabies immunoglobulin is used for the prevention of rabies in patients exposed to the rabies virus, such as through bites from suspected animals. It provides passive protection by neutralizing the virus before the body develops an immune response.
The medication is administered intramuscularly, as directed by a doctor, usually in combination with the rabies vaccine. It is important to administer it as soon as possible after exposure.
Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.
Specific anti-rabies immunoglobulin is not recommended for patients with hypersensitivity to human immunoglobulins or severe IgA deficiency.
Substance: specific rabies immunoglobulin
Date of last drug list: 01-07-2013
Commercial code: W13474001
Pharmaceutical form: solution for intramuscular injection
Quantity: 1
Product type: generic
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.